Home / Genito-urinary system and sex hormones / Tamsulosin and Solifenacin
ATC G04CA53 · Urologicals
Tamsulosin and Solifenacin shortage
As of 31 Oct 2026, Tamsulosin and Solifenacin has a reported shortage in 4 of the 5 countries we track (Italy, Spain, Austria, Belgium), covering 13 products.
Countries4/5
Products13packs or presentations
Short since23 Feb 20268 months ago
Earliest return16 Nov 2026company estimate
No return date1products
Main reasonOther
Timeline
ItalySpainAustriaBelgium
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Affected products
| Country | Product | Holder | Since | Expected back | Reason |
|---|---|---|---|---|---|
| IT | SOLIFENACINA E TAMSULOSIN MYLAN | MYLAN S.P.A. | 1 Oct 2026 | not given | Manufacturing problem Problemi produttivi |
| ES | SOLIFENACINA/TAMSULOSINA STADAFARMA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | Laboratorio Stada S.L. | 14 Jun 2026 | 29 Nov 2026 | Not stated |
| ES | SOLIFENACINA/TAMSULOSINA PENSA 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidos | Towa Pharmaceutical S.A. | 29 Sep 2026 | 29 Nov 2026 | Not stated |
| ES | DAITAL 6 MG/0,4 MG COMPRIMIDOS DE LIBERACIÓN MODIFICADA EFG, 30 comprimidos | Laboratorios Alter S.A. | 14 Oct 2026 | 29 Nov 2026 | Not stated |
| AT | Solicomp 6 mg/0,4 mg Tabletten mit veränderter Wirkstofffreisetzung, 30 Stück | Aba-Pharm GmbH | 29 Sep 2026 | 1 Feb 2027 | Manufacturing problem Verzögerung bei der Herstellung |
| BE | Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UD | Viatris GX | 23 Feb 2026 | 16 Dec 2026 | Other Other reason |
| BE | Solifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 90 | Aurobindo | 17 Apr 2026 | 15 Dec 2026 | Other Other reason |
| BE | Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 200 | Viatris GX | 7 Jul 2026 | 16 Dec 2026 | Other Other reason |
| BE | Solifenacine/Tamsulosine Viatris 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UD | Viatris GX | 5 Aug 2026 | 18 Nov 2026 | Other Other reason |
| BE | Solifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 30 (30 x 1) UD | EG | 10 Aug 2026 | 16 Nov 2026 | Manufacturing problem Delay in production |
| BE | Solifenacine/Tamsulosine EG 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UD | EG | 10 Aug 2026 | 16 Nov 2026 | Manufacturing problem Delay in production |
| BE | Solifenacine/Tamsulosine AB 6 mg - 0.4 mg tabl. modif.-rel. 30 | Aurobindo | 26 Aug 2026 | 15 Dec 2026 | Other Other reason |
| BE | Solifenacine/Tamsulosine Teva 6 mg - 0.4 mg tabl. modif.-rel. 90 (90 x 1) UD | Teva | 14 Sep 2026 | 23 Nov 2026 | Increased demand |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.